Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9425 - 9432 of 11617 results
Pharmacy Qui Tam Based On U&C Price Billing Survives Motion to Dismiss
January 15, 2015| Blog| Viewpoint
New York Passes Telemedicine Reimbursement Legislation
January 15, 2015| Blog| Viewpoint
Does a Settlement of Remaining Penn State Sanctions Issues Help the NCAA?
January 14, 2015| Blog| Viewpoint
RCEs and the New USPTO Patent Term Adjustment Rules
January 14, 2015| Blog| Viewpoint
CPSC and E-Commerce Giant Alibaba Ink Deal to Block Sale of Recalled Products to U.S. Consumers
January 14, 2015| Blog| Viewpoint
Mintz Attorneys Discuss Top Health Care Fraud Issues to Watch in 2015
January 14, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.